Oxygen

Sustainable Packaging on the Rise: Liquid Packaging Board Market Projected to Reach US$13.5 Billion by 2034 | Future Market Insights, Inc.

Retrieved on: 
Tuesday, March 12, 2024

NEWARK, Del., March 12, 2024 /PRNewswire/ -- The liquid packaging board market is estimated to record a valuation of US$ 10.4 billion in 2024. The sales of liquid packaging boards are anticipated to expand at a moderate CAGR of 2.7% through 2034. The market is expected to cross US$ 13.5 billion by 2034.  

Key Points: 
  • To learn more about key challenges, opportunities, and a manufacturer analysis, explore Future Market Insights' exclusive liquid packaging board market report.
  • NEWARK, Del., March 12, 2024 /PRNewswire/ -- The liquid packaging board market is estimated to record a valuation of US$ 10.4 billion in 2024.
  • Additionally, regulatory initiatives to reduce plastic waste and promote sustainable packaging solutions further accelerate the adoption of liquid packaging boards in various industries.
  • Clearwater Paper has announced a strategic acquisition to enter the European market to expand its worldwide reach and market dominance in the liquid packaging board area.

Sustainable Packaging on the Rise: Liquid Packaging Board Market Projected to Reach US$13.5 Billion by 2034 | Future Market Insights, Inc.

Retrieved on: 
Tuesday, March 12, 2024

NEWARK, Del., March 12, 2024 /PRNewswire/ -- The liquid packaging board market is estimated to record a valuation of US$ 10.4 billion in 2024. The sales of liquid packaging boards are anticipated to expand at a moderate CAGR of 2.7% through 2034. The market is expected to cross US$ 13.5 billion by 2034.  

Key Points: 
  • To learn more about key challenges, opportunities, and a manufacturer analysis, explore Future Market Insights' exclusive liquid packaging board market report.
  • NEWARK, Del., March 12, 2024 /PRNewswire/ -- The liquid packaging board market is estimated to record a valuation of US$ 10.4 billion in 2024.
  • Additionally, regulatory initiatives to reduce plastic waste and promote sustainable packaging solutions further accelerate the adoption of liquid packaging boards in various industries.
  • Clearwater Paper has announced a strategic acquisition to enter the European market to expand its worldwide reach and market dominance in the liquid packaging board area.

What is metabolism? A biochemist explains how different people convert energy differently − and why that matters for your health

Retrieved on: 
Friday, April 5, 2024

But what exactly is your metabolism?

Key Points: 
  • But what exactly is your metabolism?
  • Everything you expose your body to – from lifestyle to an airborne virus – influences your physical characteristics, such as your blood pressure and energy levels.

Metabolism is energy conversion

  • At the chemical level, energy metabolism begins when the three macronutrients – carbohydrates, fats and protein – are broken down atom by atom to release electrons from chemical bonds.
  • Simply put, a primary role of metabolism is to convert chemical energy into electrical energy and back into chemical energy.
  • I am a biochemist who studies the various networks of metabolism that are used as your body changes.
  • My team and I have been able to define specific traits of metabolism, such as the presence and amount of certain metabolites – products made from breaking down macronutrients – across a wide range of conditions.

Elite athletes define the upper limits

  • Elite athletes offer a prime population to study metabolic function at its best, since their network of molecular and chemical reactions must be finely tuned to compete on the world stage.
  • Traditionally, lactate threshold has been a critical measure of athletic performance by pinpointing exercise intensity when lactate starts to rise in muscles and blood.
  • When comparing the lactate thresholds of a group of elite cyclists, we found that the cyclists with higher thresholds had markers of better mitochondrial function.

Dysfunctional metabolism in diseases like COVID-19

  • Your metabolism also changes if you get an acute illness such as COVID-19.
  • In contrast to elite cyclists, COVID-19 patients have an impaired ability to burn fat that appears to persist with long COVID.


Burning fat uses a lot of oxygen. COVID-19 damages the red blood cells that deliver oxygen to organs. Because red blood cells have a limited ability to repair themselves, they might not function as well during the remainder of their roughly 120-day life span. This may partially explain why COVID symptoms last as long as they do in some people.

Blood donors define the middle

  • Blood donors, coming from every walk of life, also have a diverse range of biological traits as a study population.
  • My team and I looked at blood from over 13,000 blood donors to shed light on their metabolic diversity.
  • We found that blood from donors with higher levels of kynurenine was less likely to restore hemoglobin levels in transfusion recipients compared with donors with lower kynurenine levels.


In addition to his appointment at the University of Colorado, Travis Nemkov is an Affiliate Investigator of Vitalant Research Institute and a co-founder of Omix Technologies.

Ancient scrolls are being ‘read’ by machine learning — with human knowledge to detect language and make sense of them

Retrieved on: 
Wednesday, March 13, 2024

Using a non-invasive method that harnesses machine learning, an international trio of scholars retrieved 15 columns of ancient Greek text from within a carbonized papyrus from Herculaneum, a seaside Roman town eight kilometres southeast of Naples, Italy.

Key Points: 
  • Using a non-invasive method that harnesses machine learning, an international trio of scholars retrieved 15 columns of ancient Greek text from within a carbonized papyrus from Herculaneum, a seaside Roman town eight kilometres southeast of Naples, Italy.
  • The work of reading and analyzing the new Greek and Latin texts recovered from the papyri will fall to human beings.

Buried in ash

  • Like Pompeii, Herculaneum was buried by the catastrophic eruption of Mount Vesuvius in 79 CE.
  • But in 1752, excavation uncovered hundreds of papyrus scrolls in the library of an elaborate Roman villa.

Carbonized papyri


Starved of oxygen, the intense heat of Vesuvius’ pyroclastic flow carbonized (but did not ignite) the papyri. Resembling lumps of coal to the eye, 18th-century excavators did not immediately recognize them as ancient books.
The papyri are so brittle that many were destroyed by early attempts to access their texts. Studying them has therefore always required ingenuity. In 1754, a conservator and priest at the Vatican library devised a machine for slowly unrolling them.
More recently, multispectral photography has dramatically improved their legibility. But until now, a non-invasive method that would leave the scrolls intact remained out of reach. Its development marks a significant breakthrough. McOsker notes there are 659 items in the catalogue listed as “not unrolled,” but some of these are parts of scrolls.

Sparking innovation

  • The latter are essential as a reference point (or “control”) for innovative approaches.
  • The competition’s design encouraged transparency and collaboration: data published in the pursuit of smaller goals benefited all competitors.

Text mentions music, taste, sight

  • A PhD student studying machine learning, an engineer studying computer science and a robotics student were declared
    the victors.
  • According to McOsker, the text they retrieved mentions music twice, as well as the senses of taste and sight.

Hundreds of rolls to be studied

  • With hundreds of rolls yet to be studied, the new method of recovering the contents of the Herculaneum papyri is only getting started.
  • The production of scans at sufficiently high resolution can’t be done via ordinary equipment, but requires access to a facility with a particle accelerator.
  • Via current techniques, which involve a fair bit of manual manipulation, fully segmenting one scroll would cost US$1–5 million.

Critical minds needed

  • Their role is to analyze the model’s output of legible ancient Greek — and in so doing determine which approaches are most effective.
  • It requires mastery of ancient languages and ideas as well as the puzzle-solver’s ability to fill in the inevitable gaps.
  • For the challenge truly to succeed, we’re going to need critical minds as well as whizbang technology.


C. Michael Sampson receives funding from the Social Sciences and Humanities Research Council of Canada for 'the Books of Karanis,' a project that studies fragmentary Greek literature from the Egyptian village Karanis.

Early Pulmonary Fibrosis Detection Holds the Key to Better Health Outcomes for Canadians Living with COVID-19 and Rheumatoid Arthritis

Retrieved on: 
Wednesday, February 28, 2024

Canadians who have had COVID-19, and other chronic diseases, are experiencing Pulmonary Fibrosis (PF) at significantly higher rates than others, seemingly providing a causal link that researchers are investigating.

Key Points: 
  • Research is shedding light on the growing rate of pulmonary fibrosis (PF) being found in people suffering from long-term COVID-19.
  • One study, Post COVID-19 pulmonary fibrosis; a meta-analysis study , found that almost 45% (44.9%) of study participants began suffering from PF after contracting COVID-19.
  • Canadians suffering from long COVID are encouraged to watch for the early signs of pulmonary fibrosis, a disease that is growing in this population.
  • Dr. Janet Pope's webinar includes explanations for both physicians and thousands of people living with connective tissue diseases of what pulmonary fibrosis symptoms to watch for.

Arch Biopartners Announces Dosing of First Patient in Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury

Retrieved on: 
Thursday, March 7, 2024

TORONTO, March 07, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. , (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that patient recruitment and dosing has begun in Turkey for the Phase II trial for LSALT peptide targeting the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI).

Key Points: 
  • TORONTO, March 07, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. , (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that patient recruitment and dosing has begun in Turkey for the Phase II trial for LSALT peptide targeting the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI).
  • LSALT peptide is the Company’s lead drug candidate for preventing and treating inflammation injury in the kidneys, lungs and liver.
  • The Arch Biopartners team is currently working with hospital sites in Canada to prepare for their participation in this Phase II trial.
  • The CS-AKI Phase II trial is an international multi-center, randomized, double-blind, placebo-controlled study of LSALT peptide.

AB Science provides a summary of the live webcast held on March 4, 2024 giving an update on AB Science development

Retrieved on: 
Thursday, March 7, 2024

SUMMARY OF THE WEBCAST HELD ON MARCH 4, 2024 PROVIDING AN UPDATE ON AB SCIENCE DEVELOPMENT

Key Points: 
  • SUMMARY OF THE WEBCAST HELD ON MARCH 4, 2024 PROVIDING AN UPDATE ON AB SCIENCE DEVELOPMENT
    AB Science SA (Euronext - FR0010557264 - AB) is providing a summary of the live webcast held on March 4, 2024, giving an update on AB Science development.
  • Regarding Health Canada, a Notice of Deficiency-Withdrawal (NOD/w) has been issued and AB Science intends to submit a Request for Reconsideration.
  • Based on the supporting arguments and counterarguments outlined above, AB Science intends to submit a Request for Reconsideration.
  • AB Science will be free to continue the development of masitinib in SCD based on phase 2 data with biomarkers.

NewHydrogen CEO Steve Hill Provides ThermoLoop™ Update

Retrieved on: 
Tuesday, March 5, 2024

SANTA CLARITA, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- NewHydrogen, Inc. (OTCMKTS:NEWH), provided an update on its breakthrough ThermoLoop™ technology, which uses water and heat instead of electricity to produce the world’s cheapest green hydrogen. The company shared progress on its collaboration with the University of California Santa Barbara (UCSB) in developing the ThermoLoop™ technology.

Key Points: 
  • The company shared progress on its collaboration with the University of California Santa Barbara (UCSB) in developing the ThermoLoop™ technology.
  • “The demand for power is insatiable,” remarked Steve Hill, CEO of NewHydrogen.
  • Recently, OpenAI's CEO Sam Altman said an energy breakthrough is necessary for future artificial intelligence, which will consume vastly more power than people have expected.
  • For more information about NewHydrogen and its ThermoLoop™ technology, please visit https://newhydrogen.com/ .

GRI Bio Receives MHRA Authorization to Conduct Phase 2a Biomarker Study Evaluating GRI-0621 in the United Kingdom

Retrieved on: 
Monday, March 4, 2024

LA JOLLA, CA, March 04, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, today announced the authorization of its Clinical Trial Application (CTA) by the United Kingdom Medicines and Healthcare products Regulatory Agency (MHRA) to initiate a Phase 2a biomarker study evaluating GRI-0621 for the treatment of IPF in the UK.

Key Points: 
  • The MHRA is the UK regulatory authority, a government agency, for medicines and medical devices.
  • The MHRA is responsible for the regulation of medicines and medical devices and equipment used in healthcare and the investigation of harmful incidents.
  • “We are pleased to receive authorization from the MHRA and take a step in the global expansion of our clinical development for GRI-0621.
  • We are focused on driving this program forward and generating important data readouts this year,” Marc Hertz, PhD, Chief Executive Officer of GRI Bio.

Congress Takes Action to Reform Oxygen Payment for Medicare Beneficiaries

Retrieved on: 
Thursday, February 29, 2024

After nearly two years of concentrated work and advocacy, the American Association for Respiratory Care (AARC) and the Oxygen Reform Coalition are deeply gratified to announce that the Supplemental Oxygen Access Reform (SOAR) legislation was introduced on February 28, 2024, by Senators Cassidy (R-LA), Warner (D-VA), and Klobuchar (D-MN).

Key Points: 
  • After nearly two years of concentrated work and advocacy, the American Association for Respiratory Care (AARC) and the Oxygen Reform Coalition are deeply gratified to announce that the Supplemental Oxygen Access Reform (SOAR) legislation was introduced on February 28, 2024, by Senators Cassidy (R-LA), Warner (D-VA), and Klobuchar (D-MN).
  • The Coalition expects a House version of this bill to be introduced in the following weeks.
  • AARC prioritized the introduction of this legislation in September 2023 at its annual Washington, DC Respiratory Care Fly-In.
  • AARC Political Action Contact Team (PACT) members had more than 200 meetings with congressional members to discuss the Four Pillars for Oxygen Reform , including payment for respiratory therapists to visit and educate oxygen patients in their homes therefore improving patient outcomes.